China's Sinopharm COVID-19 Vaccines have arrived in Malaysia
2021-09-20 10:55

China National Biotech Group Company Limited and China Sinopharm International Corporation who recently signed an agreement with Malaysia's Duopharma (M) Sendirian Berhad, a wholly-owned subsidiary of Duopharma Biotech Berhad to supply an initial 2 million doses of China's Sinopharm COVID-19 vaccines, saw the first shipment arrive in Malaysia last week. The arrival of Sinopharm's COVID-19 vaccines was another significant progress in the close vaccine cooperation between China and Malaysia. China will continue to provide COVID-19 vaccines based on Malaysia's demands, so as to contribute to Malaysia's roll-out of the National Immunization Program and National Recovery Plan.






Embassy of the People's Republic of China in Malaysia All Rights Reserved